G. Guler Et Al. , "Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer," CANCER , vol.115, no.4, pp.899-908, 2009
Guler, G. Et Al. 2009. Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer. CANCER , vol.115, no.4 , 899-908.
Guler, G., Huebner, K., Himmetoglu, C., Jimenez, R. E., Costinean, S., Volinia, S., ... Pilarski, R. T.(2009). Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer. CANCER , vol.115, no.4, 899-908.
Guler, GÜLNUR Et Al. "Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer," CANCER , vol.115, no.4, 899-908, 2009
Guler, GÜLNUR Et Al. "Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer." CANCER , vol.115, no.4, pp.899-908, 2009
Guler, G. Et Al. (2009) . "Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer." CANCER , vol.115, no.4, pp.899-908.
@article{article, author={GÜLNUR GÜLER Et Al. }, title={Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer}, journal={CANCER}, year=2009, pages={899-908} }